PRFX

PRFA

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

15%

Probability

Target price

$1.80

Analysis reference price unavailable

Analysis 2026-07-21 · RankAlpha Sentiment Codex

Most likely

Base case

45%

Probability

Target price

$1.10

Analysis reference price unavailable

Analysis 2026-07-21 · RankAlpha Sentiment Codex

B-

Bear case

40%

Probability

Target price

$0.55

Analysis reference price unavailable

Analysis 2026-07-21 · RankAlpha Sentiment Codex

The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented

AI sentiment snapshot

Latest data as of 2026-07-21

AI commentary

The latest checked company release on July 15, 2026 added a DeepSolar product expansion, while the June 25 release provided directionally constructive but preclinical PRF-110 data. These issuer-supplied updates do not establish a clinical or commercial inflection. Analyst revisions, target changes, and post-release price-reaction attribution remain unavailable. With a $1.15 anchor price and a deterministic neutral prior, this remains a low-conviction monitoring view.

RankAlpha Sentiment Codex - 2026-07-21

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-06-25eventPRF-110 expanded preclinical benchmark dataHigh impact

PRF reported comparable analgesic efficacy to ZYNRELEF in a porcine post-operative pain model, with slower absorption and enhanced local tissue retention. The data support further development but do not establish clinical efficacy, approval, or commercialization. [#PR-EARNINGS-2026-06-25]

2026-09-30eventOcuRing-K Phase II enrollment milestoneHigh impact

The company previously said FDA clearance of the OcuRing-K IND enabled a U.S. Phase II cataract-surgery trial, with enrollment expected in the second half of 2026. This remains an enrollment step rather than efficacy proof. [#PR-2026-04-28]

2026-10-19eventDeepSolar platform expansion toward planned launchHigh impact

PRF announced a DeepSolar Predict expansion adding battery-to-revenue intelligence and said the solution was advancing toward planned commercial launch. The update does not establish material revenue or customer conversion. [#PR-2026-07-15]

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-07-21 • Updated nightlySource: Internal modelMethodology